Cancer treatment has advanced significantly, allowing doctors to understand the characteristics of a tumour and choose treatments based on individual patient needs. Molecular testing plays an important role in this progress by identifying specific genetic changes and other biomarkers associated with cancer. Consulting experienced Medical Oncologists in Kalyan Nagar can help patients understand whether molecular testing is appropriate for their diagnosis and how the results may influence their treatment plan.
Molecular testing is a group of laboratory tests that examine genetic changes, proteins, and other biological markers in cancer cells. These changes can provide information about how a tumour develops, grows, and responds to certain treatments.
Depending on the cancer type, doctors may recommend testing a tumour tissue sample or, in selected situations, a blood sample. Some tests examine a specific gene, while others analyse multiple genes simultaneously through a technique called next-generation sequencing. Molecular testing is commonly considered for certain lung cancers, breast cancers, colorectal cancers, and other cancer types when the results may help guide treatment decisions.
1. Helps Identify Targeted Treatment Options
One of the major benefits of molecular testing is that it can identify specific changes in cancer cells that may be treated with targeted medicines. For example, certain genetic alterations in lung cancer can help doctors determine whether a patient may benefit from a particular targeted therapy. However, not every genetic change has an approved or effective targeted treatment.
2. Supports Personalised Cancer Treatment
Cancer can behave differently from one patient to another, even when the cancer originates in the same organ. Molecular testing helps doctors understand these differences and select treatments based on the tumour’s characteristics. This approach may help avoid treatments that are unlikely to benefit a patient when reliable evidence supports an alternative option.
3. Helps Assess Immunotherapy Suitability
Some molecular and biomarker tests can help determine whether immunotherapy may be appropriate. Depending on the cancer type, doctors may consider markers such as PD-L1 expression, microsatellite instability (MSI), or mismatch repair deficiency (dMMR). These results are interpreted alongside the cancer stage, overall health, and other clinical findings.
4. Provides Information About Inherited Cancer Risk
Some genetic tests examine inherited changes that may increase a person’s risk of developing particular cancers. These tests differ from tumour molecular testing, which focuses on changes in cancer cells. When an inherited risk is suspected, doctors may recommend genetic counselling and appropriate testing to help patients and their families understand their options.
5. Helps Guide Treatment Decisions
Molecular testing can provide valuable information when doctors are choosing between available treatments or considering clinical trials. It may also help explain why a particular treatment is recommended for one patient but not another. However, testing does not guarantee a specific treatment response, and some results may not lead to a change in the treatment plan.
No. The usefulness of molecular testing depends on the cancer type, stage, available treatments, and the patient’s clinical situation. Some cancers have established testing recommendations, while others may not benefit from extensive molecular analysis.
Patients should discuss the potential benefits, limitations, cost, and turnaround time with their treating oncologist before proceeding.
Conclusion
Molecular testing is an important part of modern cancer care because it can identify relevant biomarkers, support personalised treatment decisions, and help doctors assess targeted therapy and immunotherapy options. Although it is not necessary for every patient, it can provide valuable guidance in selected cases.
Consulting experienced Medical Oncologists in Kalyan Nagar, such as Dr. Murali Subramanian, can help patients understand their testing options and make informed decisions about cancer treatment based on their diagnosis and individual needs.
FAQ’s
Molecular testing analyses genetic changes, proteins, and biomarkers in cancer cells to help doctors understand the tumour and identify potential treatment options.
It can help identify targeted therapy options, assess suitability for certain immunotherapies, and support personalised treatment decisions based on the cancer’s characteristics.
No. The need for testing depends on the cancer type, stage, available treatments, and whether the results are likely to influence treatment decisions.
Molecular testing may be useful in certain lung, breast, colorectal, ovarian, and other cancers, depending on the specific biomarkers and clinical situation.
Testing may use a tissue sample from a tumour or, in selected situations, a blood sample. The laboratory analyses specific genetic changes or biomarkers relevant to the cancer.